Jim Simons acquired 736k Bioventus shares worth $8.41M. That's 0.01% of their equity portfolio (1098th largest holding). The first Bioventus trade was made in Q2 2021. Since then Jim Simons bought shares eight more times and sold shares on six occasions. The stake costed the investor $5.2M, netting the investor a gain of 62% so far.